Answers are grounded in this paper and cite their sources.
Introduction: Intensive care treatment of multiple traumatized patients often results in transfusion of blood and coagulation products, which in many cases are administered solely based on conventional blood analyses.Beside a high socioeconomic burden, transfusion management is associated with the risk of additional in-hospital complications like acute respiratory distress syndrome (ARDS) and multiple organ dysfunction syndrome (MODS) making a specific and target-aimed coagulation-management more pronounced.In order to evaluate the impact of a rotational-thromboelastometric (ROTEM®) coagulation management towards the quantity of transfused blood products and outcome, we performed a prospective study including adult multiple traumatized patients (Injury Severity Score (ISS) ≥ 16 points) in a single level I trauma center.Material and Methods: Hemostatic therapy of multiple traumatized patients (n=62) was performed prospectively by using the ROTEM®-method and compared to a retrospectively analyzed cohort (n=109), who was treated according to conventional blood-analyses.Patients were characterized by age, body mass index (BMI), trauma injury severity scores (ISS), and Glascow Coma Scale (GCS).Evaluated parameters included the quantity of transfused blood-and coagulation-products (packed red blood cells (pRBCs), platelets (PLTs), fresh-frozen plasma (FFPs), fibrinogen (Fb), PPSB, antithrombin-III (AT-III), and tranexamic acid (TXA).In-hospital outcome was determined by presence of ARDS and multiple organ dysfunction syndrome (MODS).Logistic regression analysis was performed to identify independent influencing factors towards mortality.Results: No differences regarding demographic factors and injury severity were found between the study groups (p>0.05).However, during ICU-treatment the ROTEM®-group received less pRBCs FFPs, and PLTs (p<0.001) compared to the retrospective study cohort, whereas the administration of TXA and Fb was increased (p<0.001).At least, PPSB and AT-III did not differ between groups (p>0.05).Referring to inhospital outcome, patients in the ROTEM® group developed less frequently ARDS (p<0.001), while both groups developed multi organ dysfunction syndrome (MODS) comparably.The logistic regression analysis revealed that administration of TXA was associated with improved survival.Conclusion: Our current data clearly indicate, that in contrast to treatment based on conventional blood analyses alone, ROTEM®-based coagulation management may help to reduce blood transfusion and incidence of ARDS.Furthermore, the specific administration of TXA when using ROTEM® seems to impact the in-hospital survival of multiple traumatized patients considerably.
No takes yet. Share an insight, caveat, or question.
A 2017 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: